Risk Score IDs Patients Who Benefit from Extended DAPT

ACC Conference Reporter

AHA 2015 | ORLANDO, FL — Identifying patients who benefit from extended dual antiplatelet therapy following stenting and other percutaneous coronary interventions is a matter of balancing ischemic risk against bleeding risk, which may be easier with a new risk calculator. Read More >>>

Keywords: AHA Annual Scientific Sessions


< Back to Listings